Prelude Therapeutics Gets FDA Green Light for Groundbreaking Blood Cancer Treatment
Prelude Therapeutics receives FDA clearance to begin testing PRT12396, a targeted therapy for myeloproliferative neoplasms affecting thousands of patients.
NOTRELOAD AI
FuboTV Stock Plunges Despite ESPN Partnership and Revenue Growth
FuboTV (FUBO) shares drop 21% to $1.79 after reporting Q1 losses, despite 40% revenue jump and new ESPN distribution deal. Company plans reverse stock split.
BlackSky Wins New Defense Contracts for Gen-3 Space Intelligence Services
BlackSky secures new international defense contracts for its Gen-3 Assured services, highlighting growing demand for fast, reliable space-based intelligence.
Sangamo Therapeutics Raises $25M Through New Stock Offering
Sangamo Therapeutics announces a $25 million stock and warrant offering to strengthen its finances and support general business needs.
Anthropic’s Claude Shakes Legal Software and Publishing Stocks
New legal plug-ins from Anthropic’s Claude spark sell-off in legal software and publishing stocks as AI disruption fears grow.
FedEx Stock Gets a Boost as Major Banks Turn More Optimistic
Bernstein and Wells Fargo upgraded FedEx stock, citing better fundamentals, a freight spinoff, and strong earnings potential through 2029.